North America


Advisory Committee Alternatives: US FDA/Duke Workshop On Anaphylaxis Is One Model

 

A workshop co-hosted by the US FDA and Duke on ideas to expand access to epinephrine for anaphylaxis is the latest example of the agency holding a public meeting that could have been an advisory committee – but without the formalities.

Some Laid Off Employees Called Back At US FDA

 

Some FDA employees who were recently laid off by the Trump Administration are being called back to work, multiple sources confirmed to the Pink Sheet.

Bayer Consumer Health Expands North America And LATAM Supply Capacity

Bayer is investing $52m in its Lerma, Mexico manufacturing site, which the firm said will enable it to increase production of key OTC brands like Aspirin and Alka-Seltzer from 100m to 140m units by 2030.

US Proposal To Remove Phenylephrine From OTC Monograph Could Stress-Test Streamlined Process

 

Proposed administrative order likely is first to prompt opposition from OTC industry or other stakeholders potentially delaying or deferring the agency’s expectation for moving its proposal to a deemed final order effective one year after it would be published.

Latin America


perspectives 2026

Global CHC Industry in 2026: Self‑Care Set to Move From Policy Vision to System Delivery

 
• By 

GSCF, AESGP and ILAR agree that 2026 will see self‑care translate into more tangible system‑level action, propelled by prevention, regulatory updates and more assertive efforts to counter misleading claims.

South Africa Issues Warning About Selenium And Zinc Picolinate In Children’s Supplements

 
• By 

The South African Health Products Regulatory Authority is calling on manufacturers of food supplements marketed for children containing zinc picolinate and/or selenium to withdraw these products from the market within six months of the notice.

Bayer Consumer Health Expands North America And LATAM Supply Capacity

Bayer is investing $52m in its Lerma, Mexico manufacturing site, which the firm said will enable it to increase production of key OTC brands like Aspirin and Alka-Seltzer from 100m to 140m units by 2030.

Perrigo Q2 Results Down Nearly 11% On Formula Slump Despite Women’s Health Sales Jump On Opill

 

OTC private label/store brand product giant’s Q2 net sales down 10.7% to $1.1bn, but women’s health product sales jump 31.4% largely on Opill launched late in Q1. Biggest hit to results from infant formula business, down a reported 82% due to ongoing manufacturing quality-control remediation.

Europe


OTC Brands Aren’t Window Dressing, They Are The Door To Responsible Self-Care

 
• By 

Umbrella branding in OTC medicines supports responsible self‑care by helping consumers navigate choices, build trust and confidence, and access reliable health information, countering regulators’ long‑standing focus on risks rather than benefits, says PAGB CEO Michelle Riddalls.

perspectives 2026

From Vision to Reality: National Associations Map the Next Phase of Self‑Care in 2026

 
• By 

Industry associations in the UK, Germany and Greece expect 2026 to be the year self‑care policy is translated into day‑to‑day system change. They highlight opportunities in pharmacy, digital tools and regulatory reform, but warn that progress depends on political timing and regulatory agility.

perspectives 2026

Global CHC Industry in 2026: Self‑Care Set to Move From Policy Vision to System Delivery

 
• By 

GSCF, AESGP and ILAR agree that 2026 will see self‑care translate into more tangible system‑level action, propelled by prevention, regulatory updates and more assertive efforts to counter misleading claims.

Industry Partnership Key To Unlocking £42bn in UK NHS Prevention Savings

 
• By 

Consumer health companies can help accelerate the shift to prevention as employers and through innovation and cross-sector partnerships, unlocking a potential £42bn in savings for the UK National Health Service.

Asia


India OTC Market: $10.7bn Opportunity Awaits Pharma, But Will Regulatory Reform Flow?

 

Huge opportunities for OTC therapies loom in India, as consumerization brings structural reset in healthcare. Success stories on Rx-to-OTC transition augur well for pharma, but a predictable regulatory roadmap will be pivotal for sustainable growth.

Reckitt Seizes OTC Growth Opportunity In Emerging Markets

 
• By 

Reckitt's leadership discussed the company's growth strategy for emerging markets at a recent meeting for analysts.

Opella: Unlock Volume Growth By Expanding Access And Deepening Category Penetration

 
• By 

Negative growth in global OTC market sales volume means that “as an industry, we're not doing good enough,” argues Opella’s Asia Pacific, Middle East and Africa (AMEA) head, Carol-Ann Stewart, in this exclusive feature interview.

How Opella Is Leveraging Independence To Unleash China Growth

 
• By 

HBW Insight speaks to Opella's Asia Pacific, Middle East and Africa (AMEA) head, Carol-Anne Stewart, about the company's China growth strategy in this exclusive interview.

International


Global CHC Industry in 2026: Self‑Care Set to Move From Policy Vision to System Delivery

 
• By 

GSCF, AESGP and ILAR agree that 2026 will see self‑care translate into more tangible system‑level action, propelled by prevention, regulatory updates and more assertive efforts to counter misleading claims.

The Global Allergy Market In 2025: ‘Growth Is Back, But Not Like Before’

 
• By 

The global allergy market is “expanding again but on new terms, driven by a mix of regional strength, evolving consumer behaviors, and an increasingly diverse competitive field,” according to the latest IQVIA Consumer Health analysis.

GSCF: Self-Care Key To UN’s Noncommunicable Disease Aims

 
• By 

The United for Self-Care Coalition publishes a manifesto that it hopes will accelerate the UN’s vision set out in a recent political declaration that aims to prevent and control non-communicable diseases and promote mental health and wellbeing.

Deloitte: HCPs Driving Consumer Health Purchasing Decisions And Brand Switching

 
• By 

A recent Deloitte survey found that women are emerging as the “chief health officers” of everyday life, younger consumers are something of an enigma, being both adventurous and skeptical, and attitudes to health technologies vary geographically.